Latest Statin Stories
The Charleston-based law firm continues to investigate claims of women who developed Type II diabetes after taking the cholesterol-lowering drug Lipitor as 56 cases are centralized into multidistrict
Results presented at the American Academy of Neurology meeting CARLSBAD, Calif., April 29, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Statins are drugs designed to lower cholesterol in individuals at increased risk for cardiovascular disease, and a new study has suggests that these drugs are giving people a false sense of security.
The Firm is actively evaluating Lipitor lawsuit claims on behalf of individuals who allege their use of the cholesterol-lowering medication caused them to develop Type 2 diabetes. New
National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San
The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type-2 diabetes due to their use of the statin medication. New York, New
The Firm is evaluating Lipitor Lawsuits on behalf of patients who developed new-onset Type 2 diabetes, allegedly due to Lipitor. New York, New York (PRWEB) April
The Firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New
New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J.
Data demonstrates that the NMR LipoProfile® test provides clinically reliable information to help reduce cardiovascular events, especially in patients with diabetes and those on statin therapy WASHINGTON,
- Emitting flashes of light; glittering.